Cargando…

Identifying and prioritizing do-not-do recommendations in Dutch primary care

BACKGROUND: Low-value care provides minimal or no benefit for the patient, wastes resources, and can cause harm. Explicit do-not-do recommendations in clinical guidelines are a first step in reducing low-value care. The aim of this study was to identify and prioritize do-not-do recommendations in ge...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dulmen, Simone A., Tran, Ngoc Hue, Wiersma, Tjerk, Verkerk, Eva W., Messaoudi, Jasmine CL, Burgers, Jako S., Kool, Rudolf B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164383/
https://www.ncbi.nlm.nih.gov/pubmed/35658832
http://dx.doi.org/10.1186/s12875-022-01713-y
_version_ 1784720122035830784
author van Dulmen, Simone A.
Tran, Ngoc Hue
Wiersma, Tjerk
Verkerk, Eva W.
Messaoudi, Jasmine CL
Burgers, Jako S.
Kool, Rudolf B.
author_facet van Dulmen, Simone A.
Tran, Ngoc Hue
Wiersma, Tjerk
Verkerk, Eva W.
Messaoudi, Jasmine CL
Burgers, Jako S.
Kool, Rudolf B.
author_sort van Dulmen, Simone A.
collection PubMed
description BACKGROUND: Low-value care provides minimal or no benefit for the patient, wastes resources, and can cause harm. Explicit do-not-do recommendations in clinical guidelines are a first step in reducing low-value care. The aim of this study was to identify and prioritize do-not-do recommendations in general practice guidelines with priority for implementation. METHODS: We used a mixed method design in Dutch primary care. First, we identified do-not-do recommendations through a systematic assessment of 92 Dutch guidelines for general practitioners (GPs), resulting in 385 do-not-do recommendations. Second, we selected 146 recommendations addressing high prevalent conditions. Third, a random sample of 5000 Dutch GPs was invited for an online survey to prioritize recommendations based on the prevalence of the condition and low-value care practice, potential harm, and potential cost reduction on a scale from 1 to 5/6. Total scores could range from 4 to 22. Recommendations with a median score > 12 were included. In total, 440 GPs completed the survey. RESULTS: The selection process led to 30 prioritised recommendations. These covered drug treatments (n = 12), diagnostics (n = 10), referral to other healthcare professions (n = 5), and non-drug treatment (n = 3). CONCLUSION: Dutch clinical guidelines include many do-not-do recommendations that are perceived as highly relevant by the GPs. The list of 30 high-priority do-not-do recommendations can be used to raise awareness of low-value care among GPs. As the recommendations are supported with the latest evidence from international studies, primary healthcare professionals and policy makers worldwide can use the list for further validating the list in their local context and designing strategies to reduce low-value care.
format Online
Article
Text
id pubmed-9164383
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91643832022-06-05 Identifying and prioritizing do-not-do recommendations in Dutch primary care van Dulmen, Simone A. Tran, Ngoc Hue Wiersma, Tjerk Verkerk, Eva W. Messaoudi, Jasmine CL Burgers, Jako S. Kool, Rudolf B. BMC Prim Care Research BACKGROUND: Low-value care provides minimal or no benefit for the patient, wastes resources, and can cause harm. Explicit do-not-do recommendations in clinical guidelines are a first step in reducing low-value care. The aim of this study was to identify and prioritize do-not-do recommendations in general practice guidelines with priority for implementation. METHODS: We used a mixed method design in Dutch primary care. First, we identified do-not-do recommendations through a systematic assessment of 92 Dutch guidelines for general practitioners (GPs), resulting in 385 do-not-do recommendations. Second, we selected 146 recommendations addressing high prevalent conditions. Third, a random sample of 5000 Dutch GPs was invited for an online survey to prioritize recommendations based on the prevalence of the condition and low-value care practice, potential harm, and potential cost reduction on a scale from 1 to 5/6. Total scores could range from 4 to 22. Recommendations with a median score > 12 were included. In total, 440 GPs completed the survey. RESULTS: The selection process led to 30 prioritised recommendations. These covered drug treatments (n = 12), diagnostics (n = 10), referral to other healthcare professions (n = 5), and non-drug treatment (n = 3). CONCLUSION: Dutch clinical guidelines include many do-not-do recommendations that are perceived as highly relevant by the GPs. The list of 30 high-priority do-not-do recommendations can be used to raise awareness of low-value care among GPs. As the recommendations are supported with the latest evidence from international studies, primary healthcare professionals and policy makers worldwide can use the list for further validating the list in their local context and designing strategies to reduce low-value care. BioMed Central 2022-06-03 /pmc/articles/PMC9164383/ /pubmed/35658832 http://dx.doi.org/10.1186/s12875-022-01713-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
van Dulmen, Simone A.
Tran, Ngoc Hue
Wiersma, Tjerk
Verkerk, Eva W.
Messaoudi, Jasmine CL
Burgers, Jako S.
Kool, Rudolf B.
Identifying and prioritizing do-not-do recommendations in Dutch primary care
title Identifying and prioritizing do-not-do recommendations in Dutch primary care
title_full Identifying and prioritizing do-not-do recommendations in Dutch primary care
title_fullStr Identifying and prioritizing do-not-do recommendations in Dutch primary care
title_full_unstemmed Identifying and prioritizing do-not-do recommendations in Dutch primary care
title_short Identifying and prioritizing do-not-do recommendations in Dutch primary care
title_sort identifying and prioritizing do-not-do recommendations in dutch primary care
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164383/
https://www.ncbi.nlm.nih.gov/pubmed/35658832
http://dx.doi.org/10.1186/s12875-022-01713-y
work_keys_str_mv AT vandulmensimonea identifyingandprioritizingdonotdorecommendationsindutchprimarycare
AT tranngochue identifyingandprioritizingdonotdorecommendationsindutchprimarycare
AT wiersmatjerk identifyingandprioritizingdonotdorecommendationsindutchprimarycare
AT verkerkevaw identifyingandprioritizingdonotdorecommendationsindutchprimarycare
AT messaoudijasminecl identifyingandprioritizingdonotdorecommendationsindutchprimarycare
AT burgersjakos identifyingandprioritizingdonotdorecommendationsindutchprimarycare
AT koolrudolfb identifyingandprioritizingdonotdorecommendationsindutchprimarycare